![](https://i.imgur.com/CLvY2jA.png")
27-07-2021, 05:14 PM
EW YORK/COPENHAGEN 26 July 2021 - UNICEF and Sinovac have signed a long-term agreement for the supply of the CoronaVac inactivated virus vaccine against COVID-19 on behalf of the COVAX Facility.
Through the supply agreement, UNICEF will have access to up to 200 million doses of the vaccine in 2021 to supply participating countries and territories in the COVAX Facility’s Advance Market Commitment (AMC), as well as self-financing participants.
This is the 8th supply agreement UNICEF has signed for COVID-19 vaccines. Previous agreements have been announced with the Serum Institute of India, Pfizer, AstraZeneca, Human Vaccine, Moderna, Janssen Pharmaceutica NV and Sinopharm.
https://www.unicef.org/press-releases/un...19-vaccine
Through the supply agreement, UNICEF will have access to up to 200 million doses of the vaccine in 2021 to supply participating countries and territories in the COVAX Facility’s Advance Market Commitment (AMC), as well as self-financing participants.
This is the 8th supply agreement UNICEF has signed for COVID-19 vaccines. Previous agreements have been announced with the Serum Institute of India, Pfizer, AstraZeneca, Human Vaccine, Moderna, Janssen Pharmaceutica NV and Sinopharm.
https://www.unicef.org/press-releases/un...19-vaccine
